Biogen (BIIB) Tops Q1 EPS by $1.40
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $201.99 +4.56%
Revenue Growth %: -6.9%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: -6.9%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $9.14, $1.40 better than the analyst estimate of $7.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.41 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) tops earnings expectations but revenue falls short
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
